March 12, 2020 / 10:11 PM / 20 days ago

BRIEF-Kezar Life Sciences Reports Q4 Loss Per Share $0.50

March 12 (Reuters) - Kezar Life Sciences Inc:

* KEZAR LIFE SCIENCES REPORTS FOURTH QUARTER AND YEAR END 2019 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

* Q4 LOSS PER SHARE $0.50

* Q4 EARNINGS PER SHARE ESTIMATE $-0.54 — REFINITIV IBES DATA

* PHASE 2 MARINA, MISSION AND PRESIDIO TRIALS WITH KZR-616 ARE PROGRESSING Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below